U.S. Congress - H.R.5651 Prescription Drug User Fee Amendments of 2012
H.R.5651 - Prescription Drug User Fee Amendments of 2012
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (11)
All Bill Titles
- Short: Prescription Drug User Fee Amendments of 2012 as passed house.
- Short: Medical Device User Fee Amendments of 2012 as passed house.
- Short: Generic Drug User Fee Amendments of 2012 as passed house.
- Short: Biosimilar User Fee Act of 2012 as passed house.
- Short: Food and Drug Administration Reform Act of 2012 as passed house.
- Official: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
- Short: Food and Drug Administration Reform Act of 2012 as introduced.
- Short: Biosimilar User Fee Act of 2012 as introduced.
- Short: Generic Drug User Fee Amendments of 2012 as introduced.
- Short: Medical Device User Fee Amendments of 2012 as introduced.
- Short: Prescription Drug User Fee Amendments of 2012 as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Vote on This Bill
-
Share This Bill
More Share via Email
Comments Feed
the bill is 306 pages long, no bill needs to be that long, and with the articles describing all the special interest funding behind it, I say no, shorten it to less than 100 and then try again congress.